Nair Meera G, Herbert De'Broski R
Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA, USA.
Division of Experimental Medicine, University of California, San Francisco, CA, USA.
Immunology. 2016 Jun;148(2):115-24. doi: 10.1111/imm.12601. Epub 2016 Mar 31.
Cellular and molecular investigation of parasitic helminth infections has greatly accelerated the understanding of type 2 immune responses. However, there remains considerable debate regarding the specific leucocytes that kill parasites and whether these mechanisms are distinct from those responsible for tissue repair. Herein, we chronicle discoveries over the past decade highlighting current paradigms in type 2 immunity with a particular emphasis upon how CD4(+) T helper type 2 cells, type 2 innate lymphoid cells and alternatively activated macrophages coordinately control helminth-induced parasitism. Primarily, this review will draw from studies of the murine nematode parasite Nippostrongylus brasiliensis, which bears important similarities to the human hookworms Ancylostoma duodenale and Necator americanus. Given that one or more hookworm species currently infect millions of individuals across the globe, we propose that vaccine and/or pharmaceutical-based cure strategies targeting these affected human populations should incorporate the conceptual advances outlined herein.
对寄生性蠕虫感染的细胞和分子研究极大地加速了对2型免疫反应的理解。然而,关于杀死寄生虫的特定白细胞以及这些机制是否与负责组织修复的机制不同,仍存在相当大的争议。在此,我们记录了过去十年的发现,突出了2型免疫的当前范式,特别强调了CD4(+) 2型辅助性T细胞、2型固有淋巴细胞和替代性活化巨噬细胞如何协同控制蠕虫诱导的寄生现象。主要地,本综述将借鉴对鼠类线虫寄生虫巴西日圆线虫的研究,该寄生虫与人类钩虫十二指肠钩口线虫和美洲板口线虫有重要的相似之处。鉴于目前全球有数百万人感染一种或多种钩虫,我们建议针对这些受影响人群的基于疫苗和/或药物的治疗策略应纳入本文概述的概念进展。